Gahlot Satindra, Nasreen Najmunnisa, Johnson Judith A, Sahn Steven A, Mohammed Kamal A
North Florida/South Georgia Veterans Health System, Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida, United States of America.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
PLoS One. 2017 Jan 4;12(1):e0169245. doi: 10.1371/journal.pone.0169245. eCollection 2017.
Methicillin Resistant Staphylococcus aureus (MRSA) cause pneumonia and empyema thoraces. TLR9 activation provides protection against bacterial infections and Heme oxygenase-1 (HO-1) is known to enhance host innate immunity against bacterial infections. However, it is still unclear whether HO-1 regulates TLR-9 expression in the pleura and modulates the host innate defenses during MRSA empyema. In order to determine if HO-1 regulates host innate immune functions via modulating TLR expression, in MRSA empyema, HO-1+/+ and HO-1-/- mouse pleural mesothelial cells (PMCs) were infected with MRSA (1:10, MOI) in the presence or absence of Cobalt Protoporphyrin (CoPP) and Zinc Protoporphyrin (ZnPP) or CORM-2 (a Carbon monoxide donor) and the expression of mTLR9 and mBD14 was assessed by RT-PCR. In vivo, HO-1+/+ and HO-1-/- mice were inoculated with MRSA (5x106 CFU) intra-pleurally and host bacterial load was measured by CFU, and TLR9 expression in the pleura was determined by histochemical-immunostaining. We noticed MRSA inducing differential expression of TLR9 in HO-1+/+ and HO-1 -/- PMCs. In MRSA infected HO-1+/+ PMCs, TLR1, TLR4, and TLR9 expression was several fold higher than MRSA infected HO-1-/- PMCs. Particularly TLR9 expression was very low in MRSA infected HO-1-/- PMCs both in vivo and in vitro. Bacterial clearance was significantly higher in HO-1+/+ PMCs than compared to HO-1-/- PMCs in vitro, and blocking TLR9 activation diminished MRSA clearance significantly. In addition, HO-1-/- mice were unable to clear the MRSA bacterial load in vivo. MRSA induced TLR9 and mBD14 expression was significantly high in HO-1+/+ PMCs and it was dependent on HO-1 activity. Our findings suggest that HO-1 by modulating TLR9 expression in PMCs promotes pleural innate immunity in MRSA empyema.
耐甲氧西林金黄色葡萄球菌(MRSA)可引发肺炎和脓胸。Toll样受体9(TLR9)激活可提供针对细菌感染的保护作用,且已知血红素加氧酶-1(HO-1)可增强宿主针对细菌感染的固有免疫。然而,HO-1是否在胸膜中调节TLR-9表达并在MRSA脓胸期间调节宿主固有防御仍不清楚。为了确定HO-1是否通过调节TLR表达来调节宿主固有免疫功能,在MRSA脓胸模型中,在存在或不存在钴原卟啉(CoPP)、锌原卟啉(ZnPP)或CORM-2(一氧化碳供体)的情况下,用MRSA(1:10,感染复数)感染HO-1+/+和HO-1-/-小鼠胸膜间皮细胞(PMC),并通过逆转录聚合酶链反应(RT-PCR)评估mTLR9和mBD14的表达。在体内,向HO-1+/+和HO-1-/-小鼠胸膜内接种MRSA(5×10⁶ 菌落形成单位),通过菌落形成单位测量宿主细菌载量,并通过组织化学免疫染色确定胸膜中TLR9的表达。我们注意到MRSA在HO-1+/+和HO-1 -/- PMC中诱导TLR9的差异表达。在感染MRSA的HO-1+/+ PMC中,TLR1、TLR4和TLR9的表达比感染MRSA的HO-1-/- PMC高几倍。特别是在体内和体外,感染MRSA的HO-1-/- PMC中TLR9的表达都非常低。在体外,HO-1+/+ PMC中的细菌清除率明显高于HO-1-/- PMC,阻断TLR9激活会显著降低MRSA清除率。此外,HO-1-/-小鼠在体内无法清除MRSA细菌载量。MRSA诱导的TLR9和mBD14表达在HO-1+/+ PMC中显著升高,且依赖于HO-1活性。我们的研究结果表明,HO-1通过调节PMC中TLR9的表达促进MRSA脓胸时的胸膜固有免疫。